New-onset interstitial lung disease can be detected up to 10 years after initial negative screening in patients with systemic sclerosis, with a higher mortality risk vs those without lung involvement.

Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...

Slower oxygen recovery after a 6-minute walk test may predict poorer lung function and a higher risk for disease progression in patients with fibrotic interstitial lung disease.

The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...

WHAT IS INTERSTITIAL LUNG DISEASE? Overview of Interstitial Lung Disease (ILD):Interstitial Lung Disease refers to a group of lung conditions that cause inflammation and scarring of the ...

The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant non-small cell lung cancer (NSCLC), according to data from a trial led by ...

UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease (ILD), an increasingly common condition that is a leading reason for lung ...